Craft
Deva

Deva

Revenue

₺2.3 B

FY, 2021

Market Capitalization

₺9.4 B

2022-11-18

Deva Summary

Company summary

Overview
Deva manufactures and markets human pharmaceutical products. The Company's products include antineoplastic agents; dermatological products; antiparasitic products, insecticides, and repellents; sysyemic hormonal preparations; food supplements; and various other products, as well as electrolyte solutions. It also offers products in the areas of cardiovascular system, alimentary tract and metabolism, musculoskeletal system, nervous system, respiratory system. In addition, the Company produces and sells veterinary drugs, cologne, and medical ampoules, as well as raw materials.
Type
Public
Status
Active
Founded
1958
HQ
İstanbul, TR | view all locations
Website
http://www.deva.com.tr/en/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key people

  • Philipp Haas

    Philipp Haas, Chairman & CEO

    • Mesut Çetin

      Mesut Çetin, Deputy Chairman of the BOD and CFO

      LocationsView all

      4 locations detected

      • İstanbul, İstanbul HQ

        Turkey

        Halkalı Merkez Mah. Basın Ekspres Caddesi No:1 KÜÇÜKÇEKMECE

      • Tekirdağ

        Turkey

        İsmetpaşa Mah, Fatih Bulvarý No:6

      • Tekirdağ

        Turkey

        İSMET PAŞA MAH. ORGANİZE SANAYİ BÖLGESİ ATATÜRK CAD. 8. SOK. NO:2, İsmet Paşa

      • Tekirdağ

        Turkey

        İsmet Paşa, OSB, Fatih Bulvarý No:26

      Deva Financials

      Summary financials

      Revenue (Q2, 2022)
      ₺1.0B
      Gross profit (Q2, 2022)
      ₺548.6M
      Net income (Q2, 2022)
      ₺308.0M
      Cash (Q2, 2022)
      ₺1.1B
      EBIT (Q2, 2022)
      ₺280.0M
      Enterprise value
      $11.1B

      Footer menu